🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Transplant Recipient

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients NCT05947071Phase 210 sites📍 Stanford📍 Atlanta📍 Chicago National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Standard Dose Quadrivalent Inactivated Influenza Vaccine, High Dose Quadrivalent Inactivated Influenza Vaccine A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant NCT07508787Phase 214 sites📍 Sacramento📍 Tampa📍 Atlanta Nefro Avillion Clinical Development, LLC · Tests: Siplizumab, Rabbit anti-thymocyte globulin Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus NCT06701825Phase 41 site📍 Madrid Instituto de Investigación Hospital Universitario La Paz · Tests: Tacrolimus, Tacrolimus Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients NCT07895394Phase 41 site📍 Seoul Seoul National University Hospital · Tests: RSVPreF3 vaccination The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients NCT06639854NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Hematopoietic Cell Transplant, Letermovir Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss NCT01999361NA1 site📍 Miami Rodolfo Alejandro · Tests: Myfortic LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. NCT06018766Phase 21 site📍 San Francisco Steven Hays, MD · Tests: LAM-001, Placebo Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft NCT04989491Phase 41 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: Rituximab, control group Double Voiding and Post-transplant UTI NCT05711446NA1 site📍 New York Weill Medical College of Cornell University · Tests: Double Voiding, Regular Voiding Vascular Complications After Kidney Transplantation NCT07531966n/a3 sites📍 Aarhus📍 Copenhagen📍 Odense University of Aarhus · Tests: Catheter-based angiography, Measurement of translesional pressure gradients, Intravascular ultrasound (IVUS), Percutane… Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine NCT07600541n/a2 sites📍 Paris📍 Paris Paris Translational Research Center for Organ Transplantati… A2 to O Lung Transplants NCT05581745NA1 site📍 Toronto University Health Network, Toronto · Tests: Blood group A2 donor to blood group O recipient lung transplant surgery Cardiopulmonary Stress Testing (CPET) AlloSure Study NCT04656080n/a1 site📍 Dallas Baylor Research Institute · Tests: CPET exercise testing Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations NCT05089604Phase 41 site📍 Vancouver University of British Columbia · Tests: Tacrolimus, Immediate Release, Oral, Tacrolimus Extended Release Oral Tablet iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients NCT05968807NA1 site📍 Toronto The Hospital for Sick Children · Tests: iParent2Parent Program Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure NCT06881927Phase 41 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: Hydrocortisone Hemisuccinate: 200 mg per day., reduction of the level of immunosuppression Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies NCT00736749n/a164 sites📍 Birmingham📍 Birmingham📍 Mobile Children's Oncology Group · Tests: Assessment of Therapy Complications, Questionnaire Administration Daratumumab for Late Antibody-Mediated Rejection NCT07081126NA1 site📍 Martin University Hospital, Martin · Tests: Daratumumab (Subcutaneously), control group Muscle Oxygenation, Functional Capacity and Frailty in Kidney Transplant Recipients with and Without Inspiratory Muscle Weakness NCT06706492n/a1 site📍 Ankara Hacettepe University Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes NCT06399302n/a19 sites📍 Los Angeles📍 San Francisco📍 Stanford Duke University Immune Monitoring and Assay Development in Organ Transplant Recipients NCT01283295n/a2 sites📍 Atlanta📍 Atlanta Emory University Exercise and Diet Effects in Reducing Cardiovascular Risk in Kidney Transplant Recipients NCT06806670NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: lifestyle intervention Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT) NCT06341543NA1 site📍 Grenoble University Hospital, Grenoble · Tests: Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes)., Communication of the result of the … Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients NCT06861257n/a10 sites📍 Bologna📍 Brescia📍 Genova Fondazione IRCCS Policlinico San Matteo di Pavia Respiratory Strength Training in Heart Transplant Recipients NCT06190171NA1 site📍 Nashville Vanderbilt University Medical Center · Tests: Active respiratory muscle strength training, Sham respiratory muscle strength training Mosaic Trial for Stem Cell Transplant Recipients NCT06960993NA3 sites📍 Washington D.C.📍 Chicago📍 Nutley Northwestern University · Tests: Intervention website, Enhanced Usual Care (Control) Website Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients NCT06407232Phase 31 site📍 Madison University of Wisconsin, Madison · Tests: Letermovir Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney Transplant Recipients Receiving an Organ From EBV Positive Donors NCT07368153Phase 24 sites📍 Bern📍 Zurich📍 Lausanne University Hospital, Basel, Switzerland · Tests: indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor, placebo Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications NCT07715500NA1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: Magnetic Resonance Cholangiopancreatography Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant Recipients NCT06183892NA1 site📍 Shanghai RenJi Hospital · Tests: Tacrolimus Sustained-release Capsules
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy